Mineralocorticoid-induced increase in β-adrenergic receptors of cultured rat arterial smooth muscle cells

Allahyar Jazayeri, Walter Meyer

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

We have investigated the effect of mineralocorticoids on β-adrenergic receptors in cultured arterial smooth muscle cells. Mineralocorticoid (aldosterone) treatment resulted in a significant increase in β-adrenergic receptors measured by [3H]dihydroalprenolol (DHA) binding. This effect required at least 20 hours of incubation with aldosterone and was completely blocked by cycloheximide (10 μg/ml), indicating protein synthesis was required for this response. Aldosterone at the concentration range of 10-8-10-6M increased [3H]DHA binding, but was ineffective at 10-9 M. Scatchard analysis of [3H]DHA binding revealed that the observed significant increase in binding was due to an increased number of binding sites (P < 0.05), and that the affinity was unchanged. The aldosterone (1 × 10-8 M) effect was completely blocked by the combination of RU 38486 (10-6M) and spironolactone (10-7 M), but not by the glucocorticoid antagonist RU 38486 alone. While basal c-AMP levels were not changed by aldosterone (10-6 M) treatment, the isoproterenol (10-6 M) stimulated level of c-AMP was significantly higher in cells treated with aldosterone (P < 0.05). We conclude that aldosterone, acting through the mineralocorticoid receptor, has a direct effect on arterial smooth muscle cells mediated through modulation of β-adrenergic receptors of these cells.

Original languageEnglish (US)
Pages (from-to)987-991
Number of pages5
JournalJournal of Steroid Biochemistry
Volume33
Issue number5
DOIs
StatePublished - 1989

Fingerprint

Mineralocorticoids
Aldosterone
Adrenergic Receptors
Smooth Muscle Myocytes
Muscle
Rats
Cells
Dihydroalprenolol
Mifepristone
Adenosine Monophosphate
Mineralocorticoid Receptors
Spironolactone
Cycloheximide
Isoproterenol
Glucocorticoids
Binding Sites
Modulation

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology

Cite this

Mineralocorticoid-induced increase in β-adrenergic receptors of cultured rat arterial smooth muscle cells. / Jazayeri, Allahyar; Meyer, Walter.

In: Journal of Steroid Biochemistry, Vol. 33, No. 5, 1989, p. 987-991.

Research output: Contribution to journalArticle

@article{07d89bf600e644a1b742c0e6bea44ec0,
title = "Mineralocorticoid-induced increase in β-adrenergic receptors of cultured rat arterial smooth muscle cells",
abstract = "We have investigated the effect of mineralocorticoids on β-adrenergic receptors in cultured arterial smooth muscle cells. Mineralocorticoid (aldosterone) treatment resulted in a significant increase in β-adrenergic receptors measured by [3H]dihydroalprenolol (DHA) binding. This effect required at least 20 hours of incubation with aldosterone and was completely blocked by cycloheximide (10 μg/ml), indicating protein synthesis was required for this response. Aldosterone at the concentration range of 10-8-10-6M increased [3H]DHA binding, but was ineffective at 10-9 M. Scatchard analysis of [3H]DHA binding revealed that the observed significant increase in binding was due to an increased number of binding sites (P < 0.05), and that the affinity was unchanged. The aldosterone (1 × 10-8 M) effect was completely blocked by the combination of RU 38486 (10-6M) and spironolactone (10-7 M), but not by the glucocorticoid antagonist RU 38486 alone. While basal c-AMP levels were not changed by aldosterone (10-6 M) treatment, the isoproterenol (10-6 M) stimulated level of c-AMP was significantly higher in cells treated with aldosterone (P < 0.05). We conclude that aldosterone, acting through the mineralocorticoid receptor, has a direct effect on arterial smooth muscle cells mediated through modulation of β-adrenergic receptors of these cells.",
author = "Allahyar Jazayeri and Walter Meyer",
year = "1989",
doi = "10.1016/0022-4731(89)90250-1",
language = "English (US)",
volume = "33",
pages = "987--991",
journal = "Journal of Steroid Biochemistry and Molecular Biology",
issn = "0960-0760",
publisher = "Elsevier Limited",
number = "5",

}

TY - JOUR

T1 - Mineralocorticoid-induced increase in β-adrenergic receptors of cultured rat arterial smooth muscle cells

AU - Jazayeri, Allahyar

AU - Meyer, Walter

PY - 1989

Y1 - 1989

N2 - We have investigated the effect of mineralocorticoids on β-adrenergic receptors in cultured arterial smooth muscle cells. Mineralocorticoid (aldosterone) treatment resulted in a significant increase in β-adrenergic receptors measured by [3H]dihydroalprenolol (DHA) binding. This effect required at least 20 hours of incubation with aldosterone and was completely blocked by cycloheximide (10 μg/ml), indicating protein synthesis was required for this response. Aldosterone at the concentration range of 10-8-10-6M increased [3H]DHA binding, but was ineffective at 10-9 M. Scatchard analysis of [3H]DHA binding revealed that the observed significant increase in binding was due to an increased number of binding sites (P < 0.05), and that the affinity was unchanged. The aldosterone (1 × 10-8 M) effect was completely blocked by the combination of RU 38486 (10-6M) and spironolactone (10-7 M), but not by the glucocorticoid antagonist RU 38486 alone. While basal c-AMP levels were not changed by aldosterone (10-6 M) treatment, the isoproterenol (10-6 M) stimulated level of c-AMP was significantly higher in cells treated with aldosterone (P < 0.05). We conclude that aldosterone, acting through the mineralocorticoid receptor, has a direct effect on arterial smooth muscle cells mediated through modulation of β-adrenergic receptors of these cells.

AB - We have investigated the effect of mineralocorticoids on β-adrenergic receptors in cultured arterial smooth muscle cells. Mineralocorticoid (aldosterone) treatment resulted in a significant increase in β-adrenergic receptors measured by [3H]dihydroalprenolol (DHA) binding. This effect required at least 20 hours of incubation with aldosterone and was completely blocked by cycloheximide (10 μg/ml), indicating protein synthesis was required for this response. Aldosterone at the concentration range of 10-8-10-6M increased [3H]DHA binding, but was ineffective at 10-9 M. Scatchard analysis of [3H]DHA binding revealed that the observed significant increase in binding was due to an increased number of binding sites (P < 0.05), and that the affinity was unchanged. The aldosterone (1 × 10-8 M) effect was completely blocked by the combination of RU 38486 (10-6M) and spironolactone (10-7 M), but not by the glucocorticoid antagonist RU 38486 alone. While basal c-AMP levels were not changed by aldosterone (10-6 M) treatment, the isoproterenol (10-6 M) stimulated level of c-AMP was significantly higher in cells treated with aldosterone (P < 0.05). We conclude that aldosterone, acting through the mineralocorticoid receptor, has a direct effect on arterial smooth muscle cells mediated through modulation of β-adrenergic receptors of these cells.

UR - http://www.scopus.com/inward/record.url?scp=0024801861&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024801861&partnerID=8YFLogxK

U2 - 10.1016/0022-4731(89)90250-1

DO - 10.1016/0022-4731(89)90250-1

M3 - Article

VL - 33

SP - 987

EP - 991

JO - Journal of Steroid Biochemistry and Molecular Biology

JF - Journal of Steroid Biochemistry and Molecular Biology

SN - 0960-0760

IS - 5

ER -